Diabetes

KEASBEY, N.J. — ShopRite is offering free cholesterol and blood glucose screenings throughout February in honor of American Health Month. Walk-in screenings are available at all of its locations, with no fasting needed.

Diabetes has become a worldwide epidemic. According to data recently published by the Brussels-based International Diabetes Federation, by 2040 more than 642 million people worldwide will suffer from diabetes, up from 415 million in 2015, the last year for which the organization has statistics. In North America, this figure is expected to jump from the current 30 million cases to around 41 million.

(To view the full Category Review, click here.)

CVS Health senior educator Kristene Diggins and others involved in the fight against diabetes said they expect drug stores and retail clinics to play a bigger role in coming years.

(To view the full Category Review, click here.)

Owen Mumford is releasing an insulin injection guide to better assist healthcare professionals in educating patients on healthy injection routines. Called “Injecting with Insulin: A Guide to Good Injection Technique,” the guide will be offered in both digital and print formats as early as this month.

(To view the full Home Health Care Report, click here.)

NEW BRUNSWICK, N.J.  — Johnson and Johnson on Tuesday announced it will be evaluating "potential strategic options" for its LifeScan diabetes business, as well as other J&J diabetes banners including Animas Corp. and Calibra Medical.

The news was announced in conjunction with the company's fourth quarter earnings call, and is part of the company's ongoing portfolio management.

KEASBEY, N.J. — ShopRite is introducing a variety of health and wellness offerings for its supermarket customers throughout 2017.

These services include:

Free Eat Well, Be Happy Weight Management Classes — This six-week class teaches portion control, label reading, better-for-you cooking techniques and lifestyle maintenance.

Free Diabetes Classes — Runs throughout the year and features one-hour long sessions focusing on several aspects of diabetes. Held in partnership with ShopRite Pharmacy.

SAN DIEGO — The U.S. Department of Health and Human Services Centers for Medicaid and Medicare Services classified Dexcom’s G5 Mobile Continuous Glucose Monitoring system as “therapeutic,” meaning treatment decisions can be made using the device.

According to Dexcom, it is the only continuous glucose monitoring system that falls under this designation.